Abstract
Objective
To examine whether exposure to general anesthesia for operations and procedures after
the age of 40 years is associated with incident mild cognitive impairment (MCI) in
elderly patients.
Patients and Methods
A population-based, prospective cohort of Olmsted County, Minnesota, residents aged
70 to 89 years at enrollment, underwent baseline and 15-month interval evaluations
that included the Clinical Dementia Rating scale, a neurologic evaluation, and neuropsychological
testing. Anesthesia records after the age of 40 years until last evaluation for MCI
were abstracted. Proportional hazards regression, adjusting for other known MCI risk
factors, was used to assess whether exposure to surgical general anesthesia after
the age of 40 years is associated with the incidence of MCI.
Results
Of 1731 participants (mean age, 79 years), 536 (31.0%) developed MCI during a median
follow-up of 4.8 years. Anesthesia exposure was not associated with MCI when analyzed
as a dichotomous variable (any vs none; adjusted hazard ratio [HR], 1.07; 95% CI,
0.83-1.37; P=.61), the number of exposures (adjusted HR, 1.05; 95% CI, 0.78-1.42; adjusted HR,
1.12; 95% CI, 0.86-1.47; and adjusted HR, 1.02; 95% CI, 0.76-1.34, for 1, 2-3, and
≥4 exposures compared with no exposure as the reference; P=.73), or the total cumulative duration of exposure (adjusted HR, 1.00; 95% CI, 0.98-1.01,
per 60-minute increase; P=.83). In secondary sensitivity analyses, anesthesia after 60 years of age was associated
with incident MCI (adjusted HR, 1.25; 95% CI, 1.02-1.55; P=.04), as was exposure in the previous 20 and 10 years.
Conclusion
We found no significant association between cumulative exposure to surgical anesthesia
after 40 years of age and MCI. However, these data do not exclude the possibility
that anesthetic exposures occurring later in life may be associated with an increase
in the rate of incident MCI.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic and PersonalCorporate R&D ProfessionalsOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Mayo Clinic ProceedingsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators: International Study of Post-Operative Cognitive Dysfunction.Lancet. 1998; 351: 857-861
- Review of clinical evidence for persistent cognitive decline or incident dementia attributable to surgery or general anesthesia.J Alzheimers Dis. 2011; 24: 201-216
- Iatrogenic risk factors for Alzheimer's disease: surgery and anesthesia.J Alzheimers Dis. 2010; 22: 91-104
- Isoflurane-induced apoptosis: a potential pathogenic link between delirium and dementia.J Gerontol A Biol Sci Med Sci. 2006; 61: 1300-1306
- Postoperative impairment of cognitive function in rats: a possible role for cytokine-mediated inflammation in the hippocampus.Anesthesiology. 2007; 106: 436-443
- Spatial memory performance 2 weeks after general anesthesia in adult rats.Anesth Analg. 2005; 101: 1389-1392
- Exposure to general anesthesia and risk of Alzheimer's disease: a systematic review and meta-analysis.BMC Geriatr. 2011; 11: 83
- Anesthesia and incident dementia: a population-based, nested, case-control study.Mayo Clin Proc. 2013; 88: 552-561
- Long-term cognitive decline in older subjects was not attributable to noncardiac surgery or major illness.Anesthesiology. 2009; 111: 964-970
- An operation under general anesthesia as a risk factor for age-related cognitive decline: results from a large cross-sectional population study.J Am Geriatr Soc. 1998; 46: 1258-1265
- Anesthesia, surgery, illness and Alzheimer's disease.Prog Neuropsychopharmacol Biol Psychiatry. 2013; 47: 162-166
- Association between acute care and critical illness hospitalization and cognitive function in older adults.JAMA. 2010; 303: 763-770
- Mild cognitive impairment: clinical characterization and outcome.Arch Neurol. 1999; 56: 303-308
- Clinical practice: mild cognitive impairment.N Engl J Med. 2011; 364: 2227-2234
- The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics.Neuroepidemiology. 2008; 30: 58-69
- Prevalence of mild cognitive impairment is higher in men: The Mayo Clinic Study of Aging.Neurology. 2010; 75: 889-897
- The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging.Neurology. 2012; 78: 342-351
- Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging.Neurology. 2015; 84: 1433-1442
- History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population.Mayo Clin Proc. 2012; 87: 1202-1213
- Postmenopausal estrogen therapy and Alzheimer disease: overall negative findings.Alzheimer Dis Assoc Disord. 2006; 20: 141-146
- Subjective complaints in mild cognitive impairment make a difference.Acta Psychiatr Scand. 2010; 121: 241-242
- Incidence of dementia and Alzheimer's disease: a reanalysis of data from Rochester, Minnesota, 1975-1984.Am J Epidemiol. 1998; 148: 51-62
- Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States.Alzheimers Dement. 2011; 7: 80-93
- The short test of mental status. Correlations with standardized psychometric testing.Arch Neurol. 1991; 48: 725-728
- Cerebral blood flow in dementia.Arch Neurol. 1975; 32: 632-637
- Pathological verification of ischemic score in differentiation of dementias.Ann Neurol. 1980; 7: 486-488
- Unified Parkinson's Disease Rating Scale.in: Recent Developments in Parkinson's Disease. 2. MacMillan Healthcare Information, Florham Park, NJ1987: 153-163
- Wechsler Memory Scale–Revised.Psychological Corp, New York, NY1987
- The Clinical Dementia Rating (CDR): current version and scoring rules.Neurology. 1993; 43: 2412-2414
- Measurement of functional activities in older adults in the community.J Gerontol. 1982; 37: 323-329
- Mild cognitive impairment as a diagnostic entity.J Intern Med. 2004; 256: 183-194
- Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support.J Biomed Inform. 2009; 42: 377-381
- Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals.JAMA. 1995; 273: 1274-1278
- Postoperative cognitive dysfunction: toward the Alzheimer's disease pathomechanism hypothesis.J Alzheimers Dis. 2010; 22: 81-89
- Postoperative cognitive dysfunction after noncardiac surgery: a systematic review.Anesthesiology. 2007; 106: 572-590
- Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery.N Engl J Med. 2001; 344: 395-402
- Assessment of the emergence of Alzheimer's disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty.J Alzheimers Dis. 2005; 7: 319-324
- Cognitive changes 5 years after coronary artery bypass grafting: is there evidence of late decline?.Arch Neurol. 2001; 58: 598-604
- Cytokine dysregulation, inflammation and well-being.Neuroimmunomodulation. 2005; 12: 255-269
- The association between delirium and cognitive decline: a review of the empirical literature.Neuropsychol Rev. 2004; 14: 87-98
- Clinical, methodological and theoretical issues in the assessment of cognition after anaesthesia and surgery: a review.Eur J Anaesthesiol. 2012; 29: 409-422
- Mild cognitive impairment subtypes and vascular dementia in community-dwelling elderly people: a 3-year follow-up study.J Am Geriatr Soc. 2006; 54: 580-586
- Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins.Lancet. 2004; 363: 1139-1146
Article Info
Publication History
Published online: January 20, 2016
Footnotes
Dr Farmer is now with the Department of Surgery, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD.
Grant Support: This study was made possible by the Rochester Epidemiology Project (grant number R01-AG034676; Principal Investigator: Walter A. Rocca, MD, MPH, and Barbara P. Yawn, MD, MSc). This study was supported by grants P50 AG016574 , U01 AG006786 , K01 MH068351 , and K01 AG028573 from the National Institutes of Health , by the Robert H. and Clarice Smith and Abigail van Buren Alzheimer's Disease Research Program, the Mayo Clinic Center for Translational Sciences Activities, and grant UL1 TR000135 from the National Center for Advancing Translational Sciences .
Potential Competing Interests: Dr Knopman serves as deputy editor for the journal Neurology and serves on a data safety monitoring board for Lundbeck Pharmaceuticals and for the Dominantly Inherited Alzheimer's Disease Treatment Unit. He has served on a data safety monitoring board for Lilly Pharmaceuticals, served as a consultant to TauRX, was an investigator in clinical trials sponsored by Baxter and Elan Pharmaceuticals in the past 2 years, and receives research support from the National Institutes of Health. Dr Petersen is the chair of data monitoring committees for Pfizer and Janssen Alzheimer Immunotherapy and has served as a consultant for Roche, Merck, and Genentech. He receives royalties from the publication of Mild Cognitive Impairment by Oxford University Press. Dr Roberts receives research support from the National Institutes of Health and the Driskill Foundation and previously received research support from AbbVie Health Economics and Outcomes Research. No other disclosures were reported.
Identification
Copyright
© 2016 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.
